Experiences of GPs with incretin mimetics: a qualitative study in Germany
Loading...
Date
Publisher
Royal College of General Practitioners
Abstract
Background: Incretin mimetics are increasingly used to manage diabetes and to support weight loss in
people with obesity. However, their application by GPs in primary care settings remains underexplored.
Aim: This study aimed to investigate GPs’ healthcare experiences in relation to incretin mimetics, such
as semaglutide.
Design & setting: A qualitative study using semi-structured
interviews with GPs from Hesse in
Germany, recruited through purposive sampling. Data were collected between July 2024 and May
2025.
Method: We conducted 15 semi-structured
interviews. Data were analysed using Braun and Clarke’s
thematic analysis approach.
Results: We identified six key themes: incretin mimetics as a new treatment option in the treatment of
diabetes and obesity; patient expectations; the media as a key driver; challenges related to financial
accessibility and supply; patients’ therapy adherence; and the effects on quality of life and lifestyle
changes.
Conclusion: Our findings emphasise that facilitating patient education using supportive educational
materials might counter the lack of reliable information. Moreover, collecting both qualitative and
quantitative data on incretin mimetic usage from the patient perspective would be valuable for a more
comprehensive understanding of the use of the medication.
Metadata
License
Except where otherwise noted, this item's license is described as Attribution 4.0 International